Jeff is an accomplished biotech executive with extensive experience as an operator, director, senior advisor, and outside counsel for a broad range of public and private companies and venture investors. Jeff has served as CEO of Belharra and Ambys Medicines, President of NGM Pharmaceuticals (NASDAQ: NGM), and Senior Vice President, Corporate and Business Development at Theravance Biopharma (NASDAQ: TBPH)). His other executive roles include Chief Business Officer of Satori Pharmaceuticals, Vice President of Business Development and Corporate Strategy for Gloucester Pharmaceuticals prior to its acquisition by Celgene (NASDAQ: CELG), and multiple leadership positions in the business development and legal groups at Genentech. Jeff began his career at Wilson Sonsini, representing clients in the life science and high-tech industries. Jeff serves on the Board of Directors of TOLREMO therapeutics AG and on the Board of Directors of California Life Sciences. Jeff holds a J.D. from Columbia University School of Law, an M.LITT. from the University of St. Andrews, and a B.A. from Claremont McKenna College.

‍